AstraZeneca LP et al v. HEC Pharm Co., Ltd. et al > Summary
Court Case Number 1:15-cv-01041
Filing Date Nov 12, 2015
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
6AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Jill K. MacAlpine
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
Defendant Attorneys
7HEC Pharm Co., Ltd.
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
HEC Pharm Co., Ltd.
Attorney Name: Sara Bussiere
Bayard, P.A.
HEC Pharm Co., Ltd.
Attorney Name: Ramy E. Hanna
Foley & Lardner LLP
HEC Pharm Co., Ltd.
Attorney Name: Richard D. Kirk
Bayard, P.A.
HEC Pharm Co., Ltd.
Attorney Name: Liane M. Peterson
Foley & Lardner LLP
HEC Pharm Co., Ltd.
Attorney Name: Bradley D. Roush
Foley & Lardner LLP
HEC Pharm Co., Ltd.
Attorney Name: Vanessa Ribeiro Tiradentes
Bayard, P.A.
Counter Defendant
4Counter Claimant
HEC Pharm Co., Ltd.
Attorney Name: Stephen B. Brauerman
Bayard, P.A.
Cause
35:145 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08425934 | Pharmaceutical compositions | Apr 23, 2013 |
| 07265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Sep 4, 2007 |
